

Preexposure Prophylaxis (PrEP) Options for HIV
Oct 14, 2024
Monica Gandhi, an infectious diseases specialist and professor at UCSF, dives into the world of preexposure prophylaxis (PrEP) for HIV. She discusses the alarming rate of new HIV infections globally and the innovative therapies available, including oral medications and the dapivirine ring, which empowers women in HIV prevention. Gandhi emphasizes the critical role of adherence in maximizing PrEP's effectiveness and shares strategies to improve it. She also advocates for primary care doctors to more widely prescribe PrEP, likening it to the adoption of contraception in healthcare.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 2min
Exploring PrEP Therapies: Efficacy and Options for HIV Prevention
01:39 • 4min
Exploring the Dapivirine Ring: An Innovative HIV Prevention Method
05:18 • 2min
Strategies for Enhancing PrEP Adherence and On-Demand Options
07:36 • 3min
Enhancing PrEP Prescription in Primary Care
10:57 • 3min